Evolent Health EVH
NYSE EVH
$4.32 +0.05 (+1.17%)
At close: Sep 4, 2026 · 4:00 PM EDT

Evolent Health (EVH) Short term Debt (2020 - 2025)

Evolent Health (EVH) posted Short term Debt of $5.1 million for Q3 2025, down 97.03% on a QoQ basis from $172.1 million in Q2 2025.

Analysis

Evolent Health (EVH) Short term Debt (2020 - 2025) Analysis & Trends

Evolent Health has reported Short term Debt for 5 years, with the latest figure at $5.1 million in Q3 2025.

  • On a quarterly basis, Short term Debt changed N/A year-over-year to $5.1 million in Q3 2025; TTM through Sep 2025 was $5.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $171.5 million, changed N/A from the prior year.
  • Short term Debt was $5.1 million for Q3 2025 at Evolent Health, down from $172.1 million in the prior quarter.
  • The five-year high for Short term Debt was $172.1 million in Q2 2025, with the low at $991000.0 in Q3 2023.
  • Average Short term Debt over 4 years is $75.2 million, with a median of $26.7 million recorded in 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.76 Bn 12.64 Bn 1.16 Bn
2 RadNet 5.80 Bn 5.37 Bn 88.08 Mn
3 Concentra Group Holdings Parent 4.40 Bn 4.26 Bn 192.10 Mn
4 Privia Health 2.61 Bn 2.25 Bn -
5 Pediatrix Medical 2.20 Bn 1.79 Bn -
6 Fresenius Medical Care AG 2.11 Bn 1.41 Bn 1.52 Bn
7 Progyny 2.01 Bn 1.77 Bn 89.30 Mn
8 Surgery Partners 1.87 Bn 3.08 Bn 622.10 Mn
9 U S Physical Therapy 1.18 Bn 1.47 Bn 41.94 Mn
10 Evolent Health 488.42 Mn 346.95 Mn 80.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.12 Mn
Jun 30, 2025 172.12 Mn
Mar 31, 2025 171.79 Mn
Dec 31, 2024 171.47 Mn
Sep 30, 2023 991,000.00
Sep 30, 2021 26.70 Mn
Jun 30, 2021 26.66 Mn
Mar 31, 2021 26.61 Mn
Dec 31, 2020 26.56 Mn